{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:49:27Z","timestamp":1787701767603,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.placenta.2021.05.010","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T03:13:46Z","timestamp":1623986026000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Ex vivo human placental transfer study on recombinant Von Willebrand factor (rVWF)"],"prefix":"10.1016","volume":"111","author":[{"given":"J.","family":"Pastuschek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"B\u00e4r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"G\u00f6hner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Leidenmuehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Groten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schleu\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-595X","authenticated-orcid":false,"given":"U.R.","family":"Markert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.placenta.2021.05.010_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s002770050184","article-title":"Von Willebrand factor: molecular size and functional activity","volume":"72","author":"Furlan","year":"1996","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.placenta.2021.05.010_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu. Rev. Biochem."},{"issue":"13","key":"10.1016\/j.placenta.2021.05.010_bib3","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.placenta.2021.05.010_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (Vwd): Evidence-based diagnosis and management guidelines, the national heart, lung, and blood Institute (NHLBI) expert panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"21","key":"10.1016\/j.placenta.2021.05.010_bib5","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.placenta.2021.05.010_bib6","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1182\/blood-2014-02-557264","article-title":"The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease","volume":"123","author":"Federici","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.placenta.2021.05.010_bib7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiologic investigation of the prevalence of vonwillebrands disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.placenta.2021.05.010_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von-willebrand disease in children - a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.placenta.2021.05.010_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J. Thromb. Haemostasis"},{"issue":"7","key":"10.1016\/j.placenta.2021.05.010_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/s-0036-1587686","article-title":"Von Willebrand disease and pregnancy: a review of evidence and expert opinion","volume":"42","author":"Reynen","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.placenta.2021.05.010_bib11","doi-asserted-by":"crossref","first-page":"100572","DOI":"10.1016\/j.blre.2019.04.001","article-title":"Evolution of replacement therapy for von Willebrand disease: from plasma fraction to recombinant von Willebrand factor","author":"Peyvandi","year":"2019","journal-title":"Blood Rev."},{"issue":"9","key":"10.1016\/j.placenta.2021.05.010_bib12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/17474086.2016.1214070","article-title":"Von Willebrand factor (Vonvendi(R)): the first recombinant product licensed for the treatment of von Willebrand disease","volume":"9","author":"Franchini","year":"2016","journal-title":"Expet Rev. Hematol."},{"issue":"1","key":"10.1016\/j.placenta.2021.05.010_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2017-09-743385","article-title":"Novel therapeutics for hemophilia and other bleeding disorders","volume":"132","author":"Callaghan","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.placenta.2021.05.010_bib14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11239-019-02018-1","article-title":"Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience","volume":"49","author":"Tran","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"issue":"6","key":"10.1016\/j.placenta.2021.05.010_bib15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0002-9378(72)90909-X","article-title":"Transfer across the perfused human placenta of antipyrine, sodium and leucine","volume":"114","author":"Schneider","year":"1972","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2021.05.010_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jri.2015.03.001","article-title":"Only humans have human placentas: molecular differences between mice and humans","volume":"108","author":"Schmidt","year":"2015","journal-title":"J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.placenta.2021.05.010_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/0192623313482206","article-title":"The placenta in toxicology. Part IV: battery of toxicological test systems based on human placenta","volume":"42","author":"Gohner","year":"2014","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.placenta.2021.05.010_bib18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.placenta.2021.05.010_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0021-9258(18)56807-1","article-title":"The estimation of antipyrine in biological materials","volume":"179","author":"Brodie","year":"1949","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.placenta.2021.05.010_bib20","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.placenta.2021.05.010_bib21","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/blood-2006-06-032706","article-title":"Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels","volume":"109","author":"van Schooten","year":"2007","journal-title":"Blood"},{"issue":"Suppl A","key":"10.1016\/j.placenta.2021.05.010_bib22","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.placenta.2008.11.004","article-title":"Tolerance of human placental tissue to severe hypoxia and its relevance for dual ex vivo perfusion","volume":"30","author":"Schneider","year":"2009","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.placenta.2021.05.010_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.reprotox.2010.01.006","article-title":"Quality assessment of a placental perfusion protocol","volume":"30","author":"Mathiesen","year":"2010","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.placenta.2021.05.010_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000410678","article-title":"Effect of flow rate ratio on the diffusion of antipyrine and 3H2O in the isolated dually in vitro perfused lobe of the human placenta","volume":"13","author":"Schneider","year":"1985","journal-title":"Contrib. Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.placenta.2021.05.010_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0143-4004(85)80043-6","article-title":"Maternal to fetal movement of creatinine as a measure of perfusion efficiency and diffusional transfer in the isolated human placental lobule","volume":"6","author":"Eaton","year":"1985","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.placenta.2021.05.010_bib26","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood-2008-01-133181","article-title":"Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo","volume":"112","author":"van Schooten","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.placenta.2021.05.010_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000497416","article-title":"The elusive role of placental macrophages: the hofbauer cell","volume":"11","author":"Zulu","year":"2019","journal-title":"J Innate Immun"},{"issue":"12","key":"10.1016\/j.placenta.2021.05.010_bib28","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s11095-016-2028-8","article-title":"Placental ABC transporters: biological impact and pharmaceutical significance","volume":"33","author":"Joshi","year":"2016","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.placenta.2021.05.010_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.placenta.2021.01.025","article-title":"Fetal exposure to environmental chemicals; insights from placental perfusion studies","volume":"106","author":"Mathiesen","year":"2021","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2021.05.010_bib30","doi-asserted-by":"crossref","first-page":"985646","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"6","key":"10.1016\/j.placenta.2021.05.010_bib31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.placenta.2003.10.017","article-title":"Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies","volume":"25","author":"Bottalico","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2021.05.010_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-4939-7498-6_14","article-title":"Ex vivo dual perfusion of the human placenta: disease simulation, therapeutic pharmacokinetics and analysis of off-target effects","volume":"1710","author":"Brownbill","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.placenta.2021.05.010_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.placenta.2011.01.017","article-title":"Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by alpha1-microglobulin","volume":"32","author":"May","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2021.05.010_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ebiom.2019.06.007","article-title":"Placental effects and transfer of sildenafil in healthy and preeclamptic conditions","volume":"45","author":"Hitzerd","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.placenta.2021.05.010_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00421-017-3795-6","article-title":"Lactate metabolism: historical context, prior misinterpretations, and current understanding","volume":"118","author":"Ferguson","year":"2018","journal-title":"Eur. J. Appl. Physiol."},{"issue":"9","key":"10.1016\/j.placenta.2021.05.010_bib36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1203\/00006450-198309000-00009","article-title":"Metabolism of the human placenta perfused in vitro: glucose transfer and utilization, O2 consumption, lactate and ammonia production","volume":"17","author":"Hauguel","year":"1983","journal-title":"Pediatr. Res."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400421001764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400421001764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:25:12Z","timestamp":1778667912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400421001764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":36,"alternative-id":["S0143400421001764"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2021.05.010","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex vivo human placental transfer study on recombinant Von Willebrand factor (rVWF)","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2021.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}